共 26 条
[1]
Goldie SJ(2006)Cost-effectiveness of HIV treatment in resource-poor settings–the case of Cote d'Ivoire N Engl J Med 355 1141-53
[2]
Sanders GD(2005)Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy N Engl J Med 352 570-85
[3]
Walensky RP(2009)When to start antiretroviral therapy in resource-limited settings Ann Intern Med 151 157-66
[4]
Rothman KJ(1994)The continuing unethical use of placebo controls N Engl J Med 331 394-8
[5]
Michels KB(1997)The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials J Clin Epidemiol 50 683-91
[6]
Bucher HC(2000)Indirect comparison in evaluating relative efficacy illustrated by antimicrobial prophylaxis in colorectal surgery Control Clin Trials 21 488-97
[7]
Song F(2001)Active-control trials: how would a new agent compare with placebo? A method illustrated with clopidogrel, aspirin, and placebo Am Heart J 141 26-32
[8]
Glenny AM(2004)Clinical efficacy of antiretroviral combination therapy based on protease inhibitors or non-nucleoside analogue reverse transcriptase inhibitors: indirect comparison of controlled trials BMJ 328 249-95
[9]
Altman DG(2005)Expanded screening for HIV in the United States–an analysis of cost-effectiveness N Engl J Med 352 586-63
[10]
Fisher LD(2003)Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses BMJ 326 472-207